These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11434468)

  • 21. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
    Hoffmann-Vold AM; Aaløkken TM; Lund MB; Garen T; Midtvedt Ø; Brunborg C; Gran JT; Molberg Ø
    Arthritis Rheumatol; 2015 May; 67(8):2205-12. PubMed ID: 25916462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A longitudinal study of pulmonary function in Danish patients with systemic sclerosis.
    Jacobsen S; Halberg P; Ullman S; Høier-Madsen M; Petersen J; Mortensen J; Wiik A
    Clin Rheumatol; 1997 Jun; 16(4):384-90. PubMed ID: 9259253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography.
    Wells AU; Hansell DM; Rubens MB; King AD; Cramer D; Black CM; du Bois RM
    Arthritis Rheum; 1997 Jul; 40(7):1229-36. PubMed ID: 9214422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis.
    Abignano G; Cuomo G; Buch MH; Rosenberg WM; Valentini G; Emery P; Del Galdo F
    Ann Rheum Dis; 2014 Feb; 73(2):420-7. PubMed ID: 23511226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow-up of serum KL-6 lung fibrosis biomarker levels in 173 patients with systemic sclerosis.
    Kumánovics G; Görbe E; Minier T; Simon D; Berki T; Czirják L
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-138-44. PubMed ID: 24773853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
    Steen VD; Lucas M; Fertig N; Medsger TA
    J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of interstitial lung disease in systemic sclerosis through partitioning of lung transfer for carbon monoxide.
    Pernot J; Puzenat E; Magy-Bertrand N; Manzoni P; Gondouin A; Bourdin H; Simon-Rigaud ML; Regnard J; Degano B
    Respiration; 2012; 84(6):461-8. PubMed ID: 22301769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung function in progressive systemic sclerosis is dominated by poorly compliant lungs and stiff airways.
    Blom-Bülow B; Jonson B; Brauer K
    Eur J Respir Dis; 1985 Jan; 66(1):1-8. PubMed ID: 3979473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary involvement in systemic sclerosis (scleroderma).
    Steen VD; Owens GR; Fino GJ; Rodnan GP; Medsger TA
    Arthritis Rheum; 1985 Jul; 28(7):759-67. PubMed ID: 4015723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pulmonary hypertension screening in systemic scleroderma: a cohort study of 67 patients].
    Launay D; Hachulla E; Hatron PY; Michon-Pasturel U; Hebbar M; Queyrel V; Goullard L; Robin S; Rémy-Jardin M; Devulder B
    Rev Med Interne; 2001 Sep; 22(9):819-29. PubMed ID: 11599184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term administration of beraprost, an oral prostacyclin analogue, improves pulmonary diffusion capacity in patients with systemic sclerosis.
    Matsukawa Y; Saito O; Aoki M; Abe M; Nishinarita S; Sawada S; Horie T; Naruse S; Hiranuma M
    Prostaglandins Leukot Essent Fatty Acids; 2002 Jul; 67(1):45-9. PubMed ID: 12213435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis.
    Peters-Golden M; Wise RA; Hochberg MC; Stevens MB; Wigley FM
    Am J Med; 1984 Dec; 77(6):1027-34. PubMed ID: 6507456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical capacity in performing daily activities is reduced in scleroderma patients with early lung involvement.
    Battaglia S; Bellia M; Serafino-Agrusa L; Giardina A; Messina M; Cannizzaro F; Midiri M; Triolo G; Scichilone N
    Clin Respir J; 2017 Jan; 11(1):36-42. PubMed ID: 25832135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventilation distribution and small airway function in patients with systemic sclerosis.
    Silva BRA; Rufino R; Costa CH; Vilela VS; Levy RA; Lopes AJ
    Rev Port Pneumol (2006); 2017; 23(3):132-138. PubMed ID: 28258938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The clinical characteristics of systemic sclerosis-related pulmonary arterial hypertension].
    Wang H; Tian Z; Liu Y; Li M; Wang Q; Zeng X; Fang Q
    Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):390-3. PubMed ID: 25146407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusing capacity of the lung and nifedipine in systemic sclerosis.
    Sfikakis PP; Kyriakidis M; Vergos C; Papazoglou S; Georgiakodis F; Toutouzas P; Sfikakis P
    Arthritis Rheum; 1990 Nov; 33(11):1634-9. PubMed ID: 2242061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.